Switch to: References

Add citations

You must login to add citations.
  1. Capitalizing on transparency: Commercial surveillance and pharmaceutical marketing after the Physician Sunshine Act.Piotr Ozieranski & Shai Mulinari - 2022 - Big Data and Society 9 (1).
    How corporations surveil and influence consumers using big data tools is a major area of research and public debate. However, few studies explore it in relation to physicians in the USA, even though they have been surveilled and targeted by the pharmaceutical industry since at least the 1950s. Indeed, in 2010, concerns about the pharmaceutical industry's undue influence led to the passing of the Physician Sunshine Act, a unique piece of transparency legislation that requires companies to report their financial ties (...)
    No categories
    Direct download  
     
    Export citation  
     
    Bookmark  
  • Editorial: The personalisation of insurance: Data, behaviour and innovation.Ine Van Hoyweghen, Gert Meyers & Liz McFall - 2020 - Big Data and Society 7 (2).
    The adoption of Big Data analytics in insurance has proved controversial but there has been little analysis specifying how insurance practices are changing. Is insurance passively subject to the forces of disruptive innovation, moving away from the pooling of risk towards its personalisation or individualisation, and what might that mean in practice? This special theme situates disruptive innovations, particularly the experimental practices of behaviour-based personalisation, in the context of the practice and regulation of contemporary insurance. Our contributors argue that behaviour-based (...)
    No categories
    Direct download  
     
    Export citation  
     
    Bookmark   3 citations